Development and Validation of a Method for the Quantitative Determination of Gefitinib in a Liposomal Dosage Form
Crossref DOI link: https://doi.org/10.1007/s11094-023-02945-7
Published Online: 2023-09-07
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burdaev, N. I.
Shprakh, Z. S.
Nikolaeva, L. L.
Ignateva, E. V.
Kosenko, V. V.
Bunyatyan, N. D.
Text and Data Mining valid from 2023-08-01
Version of Record valid from 2023-08-01
Article History
Received: 27 February 2023
First Online: 7 September 2023
Conflict of Interest
: We the authors declare no conflict of interest.